229 related articles for article (PubMed ID: 27886588)
1. The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: What do we know and where are we going?
Hong JC; Salama JK
Cancer Treat Rev; 2017 Jan; 52():22-32. PubMed ID: 27886588
[TBL] [Abstract][Full Text] [Related]
2. New Strategies in Stereotactic Radiotherapy for Oligometastases.
Palma DA; Louie AV; Rodrigues GB
Clin Cancer Res; 2015 Dec; 21(23):5198-204. PubMed ID: 26626571
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiotherapy for oligometastatic disease.
Hanna GG; Landau D
Clin Oncol (R Coll Radiol); 2015 May; 27(5):290-7. PubMed ID: 25770653
[TBL] [Abstract][Full Text] [Related]
4. Spanish Society of Radiation Oncology clinical guidelines for stereotactic body radiation therapy in lymph node oligometastases.
Conde-Moreno AJ; Lopez-Guerra JL; Macias VA; Vázquez de la Torre ML; Samper Ots P; San José-Maderuelo S; Pastor Peidro J; López-Torrecilla J; Expósito-Hernández J
Clin Transl Oncol; 2016 Apr; 18(4):342-51. PubMed ID: 26329294
[TBL] [Abstract][Full Text] [Related]
5. Oligometastases: history of a hypothesis.
Milano MT; Biswas T; Simone CB; Lo SS
Ann Palliat Med; 2021 May; 10(5):5923-5930. PubMed ID: 32279519
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting?
Drazer MW; Salama JK; Hahn OM; Weichselbaum RR; Chmura SJ
Expert Rev Anticancer Ther; 2016 Jun; 16(6):625-32. PubMed ID: 27078719
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer.
Shultz DB; Filippi AR; Thariat J; Mornex F; Loo BW; Ricardi U
J Thorac Oncol; 2014 Oct; 9(10):1426-33. PubMed ID: 25170641
[TBL] [Abstract][Full Text] [Related]
8. [Stereotactic body radiation therapy and oligometastases].
Bourgier C; Azria D; Fenoglietto P; Riou O; Almaghrabi MY; Supiot S; Mornex F; Giraud P
Cancer Radiother; 2014; 18(4):337-41. PubMed ID: 24792996
[TBL] [Abstract][Full Text] [Related]
9. The evolving role of radiotherapy in treatment of oligometastatic NSCLC.
Bergsma DP; Salama JK; Singh DP; Chmura SJ; Milano MT
Expert Rev Anticancer Ther; 2015; 15(12):1459-71. PubMed ID: 26536370
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Radiation for Oligometastatic and Oligoprogressive Stage IV Breast Cancer: A Case-Based Review.
Freedman GM; Jones JA; Taunk NK
Curr Oncol; 2023 Feb; 30(2):2510-2523. PubMed ID: 36826153
[TBL] [Abstract][Full Text] [Related]
11. A multinational report of technical factors on stereotactic body radiotherapy for oligometastases.
Redmond KJ; Lo SS; Dagan R; Poon I; Foote MC; Erler D; Lee Y; Lohr F; Biswas T; Ricardi U; Sahgal A
Future Oncol; 2017 May; 13(12):1081-1089. PubMed ID: 28152619
[TBL] [Abstract][Full Text] [Related]
12. [(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results.
Pasqualetti F; Panichi M; Sainato A; Matteucci F; Galli L; Cocuzza P; Ferrazza P; Coraggio G; Pasqualetti G; Derosa L; Sollini M; Mannelli L; Ortori S; Monzani F; Ricci S; Greco C; Fabrini MG; Erba PA
Radiat Oncol; 2016 Jan; 11():9. PubMed ID: 26796633
[TBL] [Abstract][Full Text] [Related]
13. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions.
Milano MT; Katz AW; Muhs AG; Philip A; Buchholz DJ; Schell MC; Okunieff P
Cancer; 2008 Feb; 112(3):650-8. PubMed ID: 18072260
[TBL] [Abstract][Full Text] [Related]
14. A Contemporary Update on the Role of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases in the Evolving Landscape of Oligometastatic Disease Management.
Robin TP; Raben D; Schefter TE
Semin Radiat Oncol; 2018 Oct; 28(4):288-294. PubMed ID: 30309639
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy for oligometastases.
Tree AC; Khoo VS; Eeles RA; Ahmed M; Dearnaley DP; Hawkins MA; Huddart RA; Nutting CM; Ostler PJ; van As NJ
Lancet Oncol; 2013 Jan; 14(1):e28-37. PubMed ID: 23276369
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy (SBRT) in the management of extracranial oligometastatic (OM) disease.
Bhattacharya IS; Woolf DK; Hughes RJ; Shah N; Harrison M; Ostler PJ; Hoskin PJ
Br J Radiol; 2015 Apr; 88(1048):20140712. PubMed ID: 25679321
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiotherapy for oligometastatic lung tumors.
Norihisa Y; Nagata Y; Takayama K; Matsuo Y; Sakamoto T; Sakamoto M; Mizowaki T; Yano S; Hiraoka M
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):398-403. PubMed ID: 18374506
[TBL] [Abstract][Full Text] [Related]
18. Extracranial oligometastatic renal cell carcinoma: current management and future directions.
Loh J; Davis ID; Martin JM; Siva S
Future Oncol; 2014 Apr; 10(5):761-74. PubMed ID: 24799057
[TBL] [Abstract][Full Text] [Related]
19. A rationale for the targeted treatment of oligometastases with radiotherapy.
Macdermed DM; Weichselbaum RR; Salama JK
J Surg Oncol; 2008 Sep; 98(3):202-6. PubMed ID: 18618604
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy for oligometastatic non-small cell lung cancer.
Salama JK; Schild SE
Cancer Metastasis Rev; 2015 Jun; 34(2):183-93. PubMed ID: 25948377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]